KRMD KORU Medical Systems, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · korumedical.com

2.980USD-0.67%Mkt Cap: 137.59M $P/E: —1d ago

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the F…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap137.59M USD

Enterprise Value133.54M USD

Revenue (TTM)45.11M USD

Gross Profit25.60M USD

Net Income (TTM)-2.64M USD

Revenue/Share0.97 USD

Last Price2.980 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees73

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)85.71

PEG—

EV/EBITDA-136.35

EV/Revenue2.96

P/S3.07

P/B7.67

EPS (TTM)-0.04

EPS (Forward)0.04

52W Range

2.8603% of range6.608

52W High6.608 USD

52W Low2.860 USD

Profitability

Gross Margin62.26%

Oper. Margin5.21%

EBITDA Margin-2.17%

Profit Margin-6.41%

ROE-15.47%

ROA-9.35%

Growth

Revenue Growth18.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF462.40K USD

CapEx (TTM)956.49K USD

FCF Margin1.61%

FCF Yield0.53%

Net Debt-4.98M USD

Net Debt/EBITDA5.08

Balance Sheet

Debt/Equity0.21

Current Ratio2.72

Quick Ratio2.00

Book Value/Sh0.39 USD

Cash/Share0.18 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)6.250 USD

Upside (mean)+109.7%

Target Range5.000 USD – 8.000 USD

5.000+109.7% to mean8.000

# Analysts4

Ownership

Shares Out.46.17M

Float34.41M

Insiders8.21%

Institutions56.46%

Short Interest

Short Ratio5.4d

Short % Float2.60%

Short % Out.2.13%

Shares Short984.59K

Short (prev mo.)779.25K

Technical

SMA 503.353 (-11.1%)

SMA 2004.271 (-30.2%)

Beta0.39

S&P 52W Chg16.45%

Avg Vol (30d)250.39K

Avg Vol (10d)281.61K

Technical Indicators

RSI (14)34.9

MACD-0.1224

MACD Signal-0.1249

MACD Hist.+0.0026

BB Upper3.357 USD

BB Middle3.123 USD

BB Lower2.889 USD

BB Width15.00%

ATR (14)0.1458 USD

Vol Ratio (20d)0.39x